non-viral drug delivery system market 2022 – Industry Growth by 2035 Roots Analysis has announced the addition of “Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035” report to its list of offerings. Key Market Insights  Presently, over 90 non-viral drug delivery systems developers are engaged in the healthcare market, located across the globe  Currently, more than 95 non-viral drug delivery systems are offered by several players in the healthcare domain  The partnership activity for non-viral drug delivery systems in the healthcare domain has grown at a CAGR of over 40%, in the past three years, 2018-2021  The projected future opportunity for companies engaged in this field is expected to be well distributed across type of molecule, type of biologic delivered, type of technology, target therapeutic area, type of payment model and key geographical regions. Table of Contents 1. PREFACE 1.1. Scope of the Report 1.2. Research Methodology 1.3. Market Segmentations 1.4. Key Questions Answered 1.5. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Chapter Overview 3.2. Need for Targeted Drug Delivery 3.3. Advanced Approaches for Delivery of Drug Payloads 3.3.1. Nanoparticle Delivery Systems 3.3.1.1. Liposomes 3.3.1.2. Nanoparticles / Microparticles 3.3.1.3. PEGylation 3.3.1.4. Cell Penetrating Peptides (CPPs) 3.3.2. Other Drug Delivery Technologies 3.4. Future Perspectives 4. MARKET LANDSCAPE 4.1. Chapter Overview 4.2. Intracellular Drug Delivery: List of Technologies 4.2.1. Analysis by Type of Molecule Delivered 4.2.2. Analysis by Type of Biologic Delivered 4.2.3. Analysis by Type of Interaction 4.2.4. Analysis by Therapeutic Portfolio 4.3. Intracellular Drug Delivery: List of Technology Developers 4.3.1. Analysis by Year of Establishment 4.3.2. Analysis by Company Size 4.3.3. Analysis by Type of Company 4.3.4. Analysis by Location of Headquarters (By Region) 5. KEY INSIGHTS 5.1. Chapter Overview 5.2. Analysis by Type of Technology 5.3. Analysis by Company Size and Type of Molecule Delivered 5.4. Analysis by Location of Headquarters (Region-wise) and Type of Service Provider 5.5. Analysis by Company Size and Location of Headquarters 6. COMPANY COMPETITIVENESS ANALYSIS 6.1. Chapter Overview 6.2. Assumptions / Key Parameters 6.3. Methodology 6.4. Company Competitiveness Analysis: Benchmarking of Portfolio Strength 6.5. Company Competitiveness Analysis: Benchmarking of Partnership Strength 6.5.1. Company Competitiveness Analysis: Very Small Companies 6.5.2. Company Competitiveness Analysis: Small Companies 6.5.3. Company Competitiveness Analysis: Mid-Sized Companies 6.5.4. Company Competitiveness Analysis: Large and Very Large Companies 7. COMPANY PROFILES 7.1. Arcturus Therapeutics 7.2. Bio-Path 7.3. CureVac 7.4. Entos Pharmaceuticals 7.5. eTheRNA immunotherapies 7.6. Matinas BioPharma 7.7. MDimune 7.8. PCI Biotech 8. PATENT ANALYSIS 8.1. Chapter Overview 8.2. Scope and Methodology 8.3. Intracellular Drug Delivery Technologies: Patent Analysis 8.3.1. Analysis by Type of Patent 8.3.2. Analysis by Publication Year 8.3.3. Analysis by Application Year 8.3.4. Analysis by Cumulative Number of Granted Patents 8.3.5. Analysis by Cumulative Number of Patent Applications 8.3.6. Analysis by Issuing Authority 8.3.7. Analysis by Type of Player 8.3.8. Leading Players: Analysis by Number of Patents 8.3.9. Leading Inventors: Analysis by Number of Patents 8.3.10. Analysis by Top Sections 8.3.11. Intracellular Drug Delivery Technologies: Patent Benchmarking Analysis 8.4. Intracellular Drug Delivery Technologies: Patent Valuation Analysis 9. PARTNERSHIPS AND COLLABORATIONS 9.1. Chapter Overview 9.2. Partnership Models 9.3. Intracellular Drug Delivery Technologies: List of Partnerships and Collaborations 9.3.1. Cumulative Analysis of Partnerships by Year, 2015-2022 9.3.2. Analysis by Type of Partnership 9.3.3. Analysis by Year and Type of Partnership, 2015-2022 9.3.4. Analysis by Purpose of Partnership 9.3.5. Analysis by Type of Molecule Delivered 9.3.6. Analysis by Type of Biologic Delivered 9.3.7. Analysis by Target Therapeutic Area 9.3.8 Analysis by Year of Partnership and Type of Payment Model Employed, 2015-2022 9.3.9. Analysis by Year of Partnership and Type of Company, 2015-2022 9.3.10. Analysis by Purpose of Partnership and Type of Company 9.3.11. Most Active Players: Analysis by Number of Partnerships 9.3.12. Most Popular Technologies: Analysis by Number of Partnerships 9.3.13. Analysis by Region 9.3.14. Local and International Agreements 9.3.15. Intracontinental and Intercontinental Agreements 10. OPPORTUNITY ASSESSMENT FRAMEWORK: KALBACH INNOVATION MODEL, COMPETITVE ASSESSMENT FRAMEWORK AND BCG MATRIX 10.1. Chapter Overview 10.2. Kalbach Innovation Model 10.2.1. Key Assumptions and Methodology 10.2.2. Analysis by Trends in Research Activity 10.2.3. Analysis by Trends in Investment Activity 10.2.4. Analysis by Trends in Partnership Activity 10.2.5. Analysis by Number of Technologies 10.2.6. Analysis by Trends in Deal Amount 10.2.7. Analysis by Number of Google Hits 10.2.8. Qualitative and Quantitative Assessment based on Secondary and Primary Research 10.2.9. Kalbach Innovation Model: Output Analysis 10.3. Competitive Assessment Framework 10.3.1. Key Assumptions and Methodology 10.3.2. Competitive Assessment Framework: Output Analysis 10.4. BCG Matrix 10.4.1. Key Assumptions and Methodology 10.4.2. BCG Matrix: Output Analysis 11. MARKET FORECAST AND OPPORTUNITY ANALYSIS 11.1. Chapter Overview 11.2. Key Assumptions 11.3. Forecast Methodology 11.4. Global Non-Viral Intracellular Drug Delivery Technologies Market, 2022-2035 11.5. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Payment Model Employed, 2022 and 2035 11.5.1 Non-Viral Intracellular Drug Delivery Technologies Market for Milestone Payments, 2022-2035 11.5.2 Non-Viral Intracellular Drug Delivery Technologies Market for Upfront Payments, 2022-2035 11.6. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Molecule Delivered, 2022 and 2035 11.6.1 Non-Viral Intracellular Drug Delivery Technologies Market for Biologics, 2022-2035 11.6.2 Non-Viral Intracellular Drug Delivery Technologies Market for Small Molecules, 2022-2035 11.7. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Biologic Delivered, 2022 and 2035 11.7.1 Non-Viral Intracellular Drug Delivery Technologies Market for RNA, 2022-2035 11.7.2 Non-Viral Intracellular Drug Delivery Technologies Market for DNA, 2022-2035 11.7.3 Non-Viral Intracellular Drug Delivery Technologies Market for Proteins / Peptides, 2022-2035 11.7.4 Non-Viral Intracellular Drug Delivery Technologies Market for Antibodies, 2022-2035 11.8. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Technology, 2022 and 2035 11.8.1. Non-Viral Intracellular Drug Delivery Technologies Market for Nanoparticles, 2022-2035 11.8.2 Non-Viral Intracellular Drug Delivery Technologies Market for Extracellular Vesicles, 2022-2035 11.8.3 Non-Viral Intracellular Drug Delivery Technologies Market for Polymers, 2022-2035 11.8.4 Non-Viral Intracellular Drug Delivery Technologies Market for Oligonucleotides, 2022-2035 11.8.5 Non-Viral Intracellular Drug Delivery Technologies Market for Cell Penetrating Peptides, 2022-2035 11.9. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Target Therapeutic Areas, 2022 and 2035 11.9.1 Non-Viral Intracellular Drug Delivery Technologies Market for Infectious Diseases, 2022-2035 11.9.2 Non-Viral Intracellular Drug Delivery Technologies Market for Oncological Disorders, 2022-2035 11.9.3 Non-Viral Intracellular Drug Delivery Technologies Market for Genetic Disorders, 2022-2035 11.9.4 Non-Viral Intracellular Drug Delivery Technologies Market for Cardiovascular Disorders 2022-2035 11.9.5 Non-Viral Intracellular Drug Delivery Technologies Market for Hepatic Disorders, 2022-2035 11.9.6 Non-Viral Intracellular Drug Delivery Technologies Market for Neurological Disorders, 2022-2035 11.9.7 Non-Viral Intracellular Drug Delivery Technologies Market for Other Diseases, 2022-2035 11.10. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Geography, 2022 and 2035 11.10.1. Non-Viral Intracellular Drug Delivery Technologies Market in North America, 2022-2035 11.10.2. Non-Viral Intracellular Drug Delivery Technologies Market in Europe, 2022-2035 11.10.3. Non-Viral Intracellular Drug Delivery Technologies Market in Asia, 2022-2035 11.10.4. Non-Viral Intracellular Drug Delivery Technologies Market in Rest of the World, 2022- 2035 11.10.5. Non-Viral Intracellular Drug Delivery Technologies Market in Middle East and North Africa, 2022-2035 11.10.6. Non-Viral Intracellular Drug Delivery Technologies Market in Latin America, 2022-2035 12. CONCLUDING REMARKS 13. EXECUTIVE INSIGHTS 13.1. Chapter Overview 13.2. Biond Biologics 13.2.1. Interview Transcript: Tehila BenMoshe, Chief Executive Officer and Itay Friedman, Vice President Clinical Development 13.3. Carmine Therapeutics 13.3.1. Interview Transcript: Don Haut, Chief Executive Officer 13.4. Eyevensys 13.4.1. Interview Transcript: Thierry Bordet, Chief Scientific Officer 13.5. Generation Bio 13.5.1. Interview Transcript: Maren Killackey, Senior Director, Investor Relations and Communications 13.6. PCI Biotech 13.6.1. Interview Transcript: Anders Høgset, Research Director / Chief Scientific Officer 13.7. SRI International 13.7.1. Interview Transcript: Melissa Wagner, Strategic Business Executive, Biosciences Division 14. APPENDIX 1: TABULATED DATA 15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html You may also be interested in the following titles: Global Antibiotics Market Pharmaceutical Polymers / Medical Polymers Market You may also like to learn what our experts are sharing in Roots educational series: Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #nonviraldrugdeliverysystemmarket #nonviraldrugdeliverysystemmarketSize #genedeliverysystems #intracellulardelivery #intracellulardrugdelivery

Neurosurgery Market Technology, Product Scope, Demand, Business Scenario, Trends, Share, Applications, Types and Forecas 2030 The Global Neurosurgery Market report contains historical, current, and forecast estimation of the revenue generation and profits for each segment and sub-segment of the Neurosurgery market in each key region of the world. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth of the market. Furthermore, the report is attuned with the latest market changes and economic landscape with regard to the currently unfolding COVID-19 pandemic. The crisis has affected the demand and supply pattern, as well as the trends of the industry. It has also brought an economic slowdown that has affected the business of the key manufacturers of the industry. The report estimates the impact of this crisis on the current scenario and future prospects and provides a post-COVID market scenario. The global neurosurgery market size is expected to reach USD 4.91 Billion at a revenue CAGR of 4.6% in 2030, according to latest analysis by Emergen Research. The market revenue growth is primarily driven by factors such as increased utilization of neurovascular surgery, attractive medical reimbursements, growth of healthcare system throughout countries, and development of new neurovascular devices. Also, after heart illness, neurological ailments are regarded as the second most common cause of mortality worldwide. According to World Health Organization research, with rising prevalence of lifestyle illnesses, such as high blood pressure, obesity, and aging-related physiological changes in the senior population, approximately 50 million patients are at risk of acquiring neurovascular/neurological diseases. Furthermore, increasing prevalence of neurological illnesses will drive market revenue growth over the forecast period Download a sample report to get a detailed overview of the report: @ https://www.emergenresearch.com/request-sample/1323 Additional information offered by the report: Along with a complete overview of the global Neurosurgery market, the report provides detailed scrutiny of the diverse market trends observed on both regional and global levels. The report elaborates on the global Neurosurgery market size and share governed by the major geographies. It performs a precise market growth forecast analysis, cost analysis, and a study of the micro- and macro-economic indicators. It further presents a detailed description of the company profiles of the key market contenders. In conclusion, the Neurosurgery Market report is an exhaustive database that will help readers formulate lucrative strategies. The Neurosurgery Market report studies the latest economic scenario with value, drivers, constraints, growth opportunities, challenges, demand and supply ratio, production capacity, import/export status, growth rate, and others. Additionally, the report also undertakes SWOT Analysis and Porter’s Five Forces Analysis to study the leading companies. The major companies Covered in the report are: B. Braun SE, Medtronic, Medical Device Business Services, Inc. (J&J Subsidiary), Boston Scientific Corporation, Stryker, Terumo Corporation, Integra LifeSciences, Penumbra Inc., Adeor Medical AG, Resonetics, and Clarus Medical LLC The report, additionally, offers a comprehensive SWOT analysis and Porter’s Five Forces analysis to offer a better understanding of the competitive landscape of the industry. It also covers strategies adopted by prominent players such as mergers and acquisitions, collaborations, joint ventures, product launches, and brand promotions, among others. The report aims to offer the readers a holistic understanding of the relevant features of the industry. Browse the Complete Research Report – Industry Analysis, Size, Share, Growth, Trends @ https://www.emergenresearch.com/industry-report/neurosurgery-market Analysis of the segments and their growth projection is carried out by extensive historical and current analysis of the market scenario. Further, the report offers details about the factors and features of the Neurosurgery market expected to boost the growth of the industry in the coming years. Neurosurgery Market Segmentation: Surgery Type Outlook (Revenue, USD Billion; 2019-2030) Functional Neurosurgery Neuro-oncology Neurotraumatology Neurovascular Surgery Pediatric neurosurgery Spine Surgery Others Device Type Outlook (Revenue, USD Billion; 2019-2030) Neuro Interventional Devices Neurovascular Embolization Devices Embolization Coils Liquid Embolic Systems Flow Diversion Stents Aneurysm Clips Neurovascular Coiling Assist Devices Coiling Assist Stents Coiling Assist Balloons Neurovascular Thrombectomy Devices Stent Retrievers Aspiration Retrievers Microcatheters Intracranial Stents Others Neuroendoscopes Flexible Neuroendoscopes Rigid Neuroendoscopes Neurosurgical Drills Pneumatic Neurosurgical Drills Electrical Neurosurgical Drills Radiosurgery Systems Linear Accelerator Radiosurgery Systems GammaKnife Radiosurgery Systems Dura Substitutes Biological Dura Substitutes Synthetic Dura Substitutes Neurosurgical Ablation Devices MRI Guided Focused Ultrasound Systems MRI Guided Laser Therapy Systems MRI Guided RF Ablation Systems Neurosurgery Instruments Tissue Retractors Forceps Head Frames Cervical Plating systems Perforators Application Outlook (Revenue, USD Billion; 2019-2030) Cancerous Brain Spine and Skull Base Tumors Skull Fractures Traumatic Brain Injuries Craniofacial Trauma Spinal Cord Injuries Hydrocephalus Pediatric Brain Tumors Craniosynostosis Spinal Cord Tumors Syringomyelia Chiari Malformation Parkinson’s Disease Tourette’s Syndrome Others Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1323 Key Questions Answered in the Report: What is the growth rate of the Neurosurgery market? What is the anticipated market valuation of Neurosurgery industry by? What are the key growth driving and restraining factors of the Neurosurgery market? Who are the prominent players operating in the market? What are the key strategies adopted by these companies? What are the key opportunities and growth prospects of the Neurosurgery industry over the forecast period? Which region is expected to show significant growth in the coming years? Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-history/1323 Thank you for reading our report. Please get in touch with us if you have any query regarding the report or its customization. Our team will ensure the report is best suited to your needs. Explore Related Reports From Emergen Research: https://www.blogger.com/profile/08231267860928283577 metastatic urothelial carcinoma market https://www.emergenresearch.com/industry-report/metastatic-urothelial-carcinoma-market advanced wound care market https://www.emergenresearch.com/industry-report/advanced-wound-care-market diabetic ketoacidosis market https://www.emergenresearch.com/industry-report/diabetic-ketoacidosis-market pharmacovigilance market https://www.emergenresearch.com/industry-report/pharmacovigilance-market cannabis market https://www.emergenresearch.com/industry-report/cannabis-market depression treatment market https://www.emergenresearch.com/industry-report/depression-treatment-market beacon technology market https://www.emergenresearch.com/industry-report/beacon-technology-market pectin market https://www.emergenresearch.com/industry-report/pectin-market commercial vehicle sensors market https://www.emergenresearch.com/industry-report/commercial-vehicle-sensors-market green construction market https://www.emergenresearch.com/industry-report/green-construction-market About Us: Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: www.emergenresearch.com Direct Line: +1 (604) 757-9756 E-mail: sales@emergenresearch.com Visit for More Insights: https://www.emergenresearch.com/insights Trending Report: food tech market|Water Based Adhesives Market Trending Title: Wearable Technology Market |Virtual power plant Market